{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:44:12Z","timestamp":1781592252375,"version":"3.54.5"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2010,11,15]],"date-time":"2010-11-15T00:00:00Z","timestamp":1289779200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0015478","type":"journal-article","created":{"date-parts":[[2010,11,15]],"date-time":"2010-11-15T20:19:37Z","timestamp":1289852377000},"page":"e15478","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Temporal Pattern of ICAM-I Mediated Regulatory T Cell Recruitment to Sites of Inflammation in Adoptive Transfer Model of Multiple Sclerosis"],"prefix":"10.1371","volume":"5","author":[{"given":"Sebastian","family":"Doerck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"G\u00f6bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gesa","family":"Weise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Schneider-Hohendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Reinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hauff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Linker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"M\u00e4urer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven G.","family":"Meuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Wiendl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,11,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/ni1572","article-title":"The Foxp3+ regulatory T cell: a jack of all trades, master of regulation.","volume":"9","author":"Q Tang","year":"2008","journal-title":"Nat Immunol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/art.11063","article-title":"CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis.","volume":"48","author":"ME Morgan","year":"2003","journal-title":"Arthritis Rheum"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.4049\/jimmunol.169.9.4712","article-title":"Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis.","volume":"169","author":"AP Kohm","year":"2002","journal-title":"J Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nm1564","article-title":"Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation.","volume":"13","author":"T Korn","year":"2007","journal-title":"Nat Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20040179","article-title":"CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion.","volume":"199","author":"AE Herman","year":"2004","journal-title":"J Exp Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1196\/annals.1361.048","article-title":"Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.","volume":"1051","author":"CA Piccirillo","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/ncpneuro0832","article-title":"The role of regulatory T cells in multiple sclerosis.","volume":"4","author":"AL Zozulya","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/intimm\/10.12.1969","article-title":"Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic\/suppressive state.","volume":"10","author":"T Takahashi","year":"1998","journal-title":"Int Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","article-title":"Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.","volume":"22","author":"S Sakaguchi","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4049\/jimmunol.178.1.301","article-title":"FoxP3+ T cells undergo conventional first switch to lymphoid tissue homing receptors in thymus but accelerated second switch to nonlymphoid tissue homing receptors in secondary lymphoid tissues.","volume":"178","author":"JH Lee","year":"2007","journal-title":"J Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"958","DOI":"10.4049\/jimmunol.179.2.958","article-title":"The inflamed central nervous system drives the activation and rapid proliferation of Foxp3+ regulatory T cells.","volume":"179","author":"RA O'Connor","year":"2007","journal-title":"J Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jneuroim.2005.11.003","article-title":"CD25 regulatory T cells determine secondary but not primary remission in EAE: impact on long-term disease progression.","volume":"172","author":"D Gartner","year":"2006","journal-title":"J Neuroimmunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1750-3639.2007.00067.x","article-title":"Inflammatory cell migration into the central nervous system: a few new twists on an old tale.","volume":"17","author":"S Man","year":"2007","journal-title":"Brain Pathol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00702-005-0409-y","article-title":"Molecular mechanisms involved in T cell migration across the blood-brain barrier.","volume":"113","author":"B Engelhardt","year":"2006","journal-title":"J Neural Transm"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier.","volume":"37","author":"NJ Abbott","year":"2010","journal-title":"Neurobiol Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0166-2236(98)01287-9","article-title":"The role of integrins in immune-mediated diseases of the nervous system.","volume":"22","author":"JJ Archelos","year":"1999","journal-title":"Trends Neurosci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1172\/JCI4271","article-title":"The development of experimental autoimmune encephalomyelitis in the mouse requires alpha4-integrin but not alpha4beta7-integrin.","volume":"102","author":"B Engelhardt","year":"1998","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00441-003-0751-z","article-title":"Development of the blood-brain barrier.","volume":"314","author":"B Engelhardt","year":"2003","journal-title":"Cell Tissue Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1002\/1521-4141(200212)32:12<3598::AID-IMMU3598>3.0.CO;2-6","article-title":"Encephalitogenic T cells use LFA-1 for transendothelial migration but not during capture and initial adhesion strengthening in healthy spinal cord microvessels in vivo.","volume":"32","author":"M Laschinger","year":"2002","journal-title":"Eur J Immunol"},{"key":"ref20","first-page":"51","article-title":"The role of alpha 4-integrin in T lymphocyte migration into the inflamed and noninflamed central nervous system.","volume":"231","author":"B Engelhardt","year":"1998","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI12440","article-title":"Alpha4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels.","volume":"108","author":"P Vajkoczy","year":"2001","journal-title":"J Clin Invest"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1357-4310(99)01639-1","article-title":"Animal models for autoimmune demyelinating disorders of the nervous system.","volume":"6","author":"R Gold","year":"2000","journal-title":"Mol Med Today"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/awl075","article-title":"Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research.","volume":"129","author":"R Gold","year":"2006","journal-title":"Brain"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jaut.2005.09.019","article-title":"In vivo molecular imaging of adhesion molecules in experimental autoimmune encephalomyelitis (EAE).","volume":"25","author":"RA Linker","year":"2005","journal-title":"J Autoimmun"},{"key":"ref25","first-page":"2","article-title":"Sensitive particle acoustic quantification (SPAQ): a new ultrasound-based approach for the quantification of ultrasound contrast media in high concentrations.","volume":"40","author":"M Reinhardt","year":"2005","journal-title":"Invest Radiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nm0602-620","article-title":"CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation.","volume":"8","author":"RA Linker","year":"2002","journal-title":"Nat Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1523\/JNEUROSCI.4794-04.2005","article-title":"Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS.","volume":"25","author":"T Magnus","year":"2005","journal-title":"J Neurosci"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1084\/jem.20051060","article-title":"Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis.","volume":"202","author":"N Beyersdorf","year":"2005","journal-title":"J Exp Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.coi.2005.09.002","article-title":"How do CD4+CD25+ regulatory T cells control autoimmunity?","volume":"17","author":"JA Bluestone","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.4049\/jimmunol.175.5.3025","article-title":"Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system.","volume":"175","author":"MJ McGeachy","year":"2005","journal-title":"J Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ana.21705","article-title":"Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.","volume":"66","author":"YH Huang","year":"2009","journal-title":"Ann Neurol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2249.2006.03271.x","article-title":"Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients.","volume":"147","author":"U Feger","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.21944","article-title":"Role of CD8+ CD25+ Foxp3+ regulatory T cells in multiple sclerosis.","volume":"67","author":"J Correale","year":"2010","journal-title":"Ann Neurol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1093\/brain\/awl213","article-title":"Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis.","volume":"129","author":"D Tischner","year":"2006","journal-title":"Brain"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.4049\/jimmunol.175.8.5058","article-title":"Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression.","volume":"175","author":"T Hiura","year":"2005","journal-title":"J Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0165-5728(96)00064-1","article-title":"Partial inhibition of AT-EAE by an antibody to ICAM-1: clinico-histological and MRI studies.","volume":"69","author":"SP Morrissey","year":"1996","journal-title":"J Neuroimmunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.410340209","article-title":"Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1.","volume":"34","author":"JJ Archelos","year":"1993","journal-title":"Ann Neurol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0165-5728(99)00064-8","article-title":"Contrasting effects of anti-adhesion molecule therapy in experimental allergic encephalomyelitis and Theiler&apos;s murine encephalomyelitis.","volume":"97","author":"JW Rose","year":"1999","journal-title":"J Neuroimmunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0165-5728(93)90175-X","article-title":"ICAM-1-dependent pathway is not critically involved in the inflammatory process of autoimmune encephalomyelitis or in cytokine-induced inflammation of the central nervous system.","volume":"45","author":"DO Willenborg","year":"1993","journal-title":"J Neuroimmunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa044396","article-title":"Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.","volume":"354","author":"RA Rudick","year":"2006","journal-title":"N Engl J Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.","volume":"354","author":"CH Polman","year":"2006","journal-title":"N Engl J Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0015478","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T07:23:53Z","timestamp":1711956233000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0015478"}},"subtitle":[],"editor":[{"given":"Christoph","family":"Kleinschnitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,11,15]]},"references-count":41,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2010,11,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0015478","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,15]]}}}